Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbamazepine Extended-Release Tablets.
28 July, 2025, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval...
Tag : Alembic
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Doxorubicin Hydrochloride Liposome Injection
30th June, 2025 Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from...
Alembic honoured with Guinness World Record for Hypertension Awareness Milestone
~Over 15,000 Healthcare professionals take a pledge towards better hypertension management~ 12 November 2024, Bengaluru:...
Alembic Pharmaceuticals announces USFDA Final Approval for Lamotrigine Extended-Release Tablets USP, 200 mg, 250 mg, and 300 mg.
3rd October 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from...
Alembic Pharmaceuticals announces USFDA Tentative Approval for Ivosidenib Tablets 250 mg
4 July 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from...